These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2185045)

  • 41. A unique case of massive ascites before ovulation associated with gonadotropin therapy.
    Akman MA; Garcia JE; Katz E
    Fertil Steril; 1996 Dec; 66(6):1026-7. PubMed ID: 8941074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Severe ovarian hyperstimulation syndrome - case study].
    Pokorná M
    Ceska Gynekol; 2015 Dec; 80(6):447-50. PubMed ID: 26741160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Features of the Renin-angiotensin system in ascites and pleural effusion during severe ovarian hyperstimulation syndrome.
    Delbaere A; Bergmann PJ; Englert Y
    J Assist Reprod Genet; 1997 May; 14(5):241-4. PubMed ID: 9147235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Abramov Y; Schenker JG; Lewin A; Kafka I; Jaffe H; Barak V
    Fertil Steril; 2001 Jul; 76(1):51-7. PubMed ID: 11438319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome.
    Tomazevic T; Meden-Vrtovec H
    J Assist Reprod Genet; 1996 Apr; 13(4):282-6. PubMed ID: 8777340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovarian cyst aspiration: a therapeutic approach to ovarian hyperstimulation syndrome.
    Fakih H; Bello S
    Fertil Steril; 1992 Oct; 58(4):829-32. PubMed ID: 1426334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Update on ovarian hyperstimulation syndrome].
    Delbaere A; Rodesch C; Englert Y
    Rev Med Brux; 1995 Nov; 16(5):354-60. PubMed ID: 7501911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autologous protein reinfusion in severe ovary hyperstimulation syndrome.
    Splendiani G; Mazzarella V; Tozzo C; Elli M; Casciani CU
    J Am Coll Surg; 1994 Jul; 179(1):25-8. PubMed ID: 8019720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship of gonadotropin-releasing hormone, danazol, and prostaglandin blockade to ovarian enlargement and ascites formation of the ovarian hyperstimulation syndrome in the rabbit.
    Pride SM; Yuen BH; Moon YS; Leung PC
    Am J Obstet Gynecol; 1986 May; 154(5):1155-60. PubMed ID: 3085504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The ovarian hyperstimulation syndrome. Anesthesiologic aspects based on a severe case].
    Heylen I; Pichlmayr I; Schlösser HW
    Anaesthesist; 1990 Jun; 39(6):330-2. PubMed ID: 2375489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Outcome of follicular aspiration of selection phase in patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation].
    Zhu WJ; Li XM; Chen XM; Zhang L
    Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):522-5. PubMed ID: 15363349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome.
    Abuzeid MI; Nassar Z; Massaad Z; Weiss M; Ashraf M; Fakih M
    Hum Reprod; 2003 Feb; 18(2):370-3. PubMed ID: 12571176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experience with transvaginal ultrasound-guided aspiration of supernumerary follicles for the prevention of multiple pregnancies after ovulation induction and intrauterine insemination.
    De Geyter C; De Geyter M; Castro E; Bals-Pratsch M; Nieschlag E; Schneider HP
    Fertil Steril; 1996 Jun; 65(6):1163-8. PubMed ID: 8641491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emergency ultrasound diagnosis of ovarian hyperstimulation syndrome: case report.
    Frasure SE; Rempell JS; Noble VE; Liteplo AS
    J Emerg Med; 2012 Aug; 43(2):e129-32. PubMed ID: 22525699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ovarian hyperstimulation syndrome. A case report.
    Moodley TR; Pillay M
    S Afr Med J; 1985 Aug; 68(5):336-7. PubMed ID: 3929400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Avoidance of cancellation of potential hyperstimulation cycles by conversion to in vitro fertilization-embryo transfer.
    Lessing JB; Amit A; Libal Y; Yovel I; Kogosowski A; Peyser MR
    Fertil Steril; 1991 Jul; 56(1):75-8. PubMed ID: 1906019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Gonadotropins--their side effects].
    Tojo S; Nakano R; Washio M
    Horumon To Rinsho; 1972 Oct; 20(10):787-95. PubMed ID: 4568942
    [No Abstract]   [Full Text] [Related]  

  • 59. Transvaginal drainage of ascites as an alternative to abdominal paracentesis in patients with severe ovarian hyperstimulation syndrome, obesity, and generalized edema.
    Raziel A; Friedler S; Schachter M; Strassburger D; Bukovsky I; Ron-El R
    Fertil Steril; 1998 Apr; 69(4):780-3. PubMed ID: 9548173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of montelukast and cabergoline for prevention of ovarian hyperstimulation syndrome: in an experimental rat model.
    Akman L; Sahin G; Erbas O; Aktug H; Akdogan A; Goker EN; Taskiran D; Tavmergen E
    Gynecol Endocrinol; 2015 May; 31(5):369-73. PubMed ID: 25599748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.